There’s reason to remain bullish about Merck’s growth prospects in the long run. And at a discounted price, the stock could ...

Shares of pharmaceutical company Merck (NYSE: MRK) were recently down about 40% over the past year, partly due to concerns ...

Merck & Co., Inc. (NYSE:MRK) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. Analyst Asad Haider from ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration ...

The Dow Jones Industrial Average (DJINDICES: ^DJI) index edged 3.9% higher in May, with 70% of its 30 constituent stocks ...

Merck’s Curiosity Cube brings hands-on science to Johannesburg, inspiring kids aged 8–13 to explore STEM and imagine futures in science.

During a Community Case Forum event, Adil Daud, MD, discussed immunotherapy options for cutaneous squamous cell carcinoma.

The debate continues over the potential of measurable residual disease to transform research and clinical care in hematology.

Ravindra Uppaluri, MD, PhD, discusses the background regarding locally advanced head and neck cancer and what the trial design of KEYNOTE-689 entailed.

At the first ring of the phone, Eddy Merckx, who turns 80 in two days, answers. And, surprisingly, catching off guard, he ...

Tadej Pogacar has once again demonstrated in the Critérium du Dauphiné that he is the best cyclist in the world. Nine stage ...

Wall Street's major averages opened lower on Thursday. Investors will keep an eye out for tariff announcements in the coming weeks. See more updates here.